Chemoradiation for locally advanced non-small cell lung cancer;Chimioradiothérapie exclusive des cancers bronchiques non à petites cellules localement évolués

Cancer/Radiotherapie

Volumn 11, Issue 1-2, 2007, Pages 67-76

  Girard, N ^a   Mornex, F ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Chemoradiation; Chemotherapy; Gemcitabine; Non small cell lung cancer; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEFITINIB; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LEVAMISOLE; METHOTREXATE; MITOMYCIN; NAVELBINE; NITROSOUREA; PACLITAXEL; PROCARBAZINE; VINDESINE;

ADVANCED CANCER; BLOOD TOXICITY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGITIS; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 34047193152     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.11.002     Document Type: Short Survey

References (70)

1. Albain K.S., Swann R.S., Rusch V.R., Turrisi A.T., Shepherd F.A., Smith C.J., et al. North American Lung Cancer Intergroup. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309) (abstract). Proc. Am. Soc. Clin. Oncol. 24 (2005) 624S
2. Ball D., Bishop J., Smith J., O'Brien P., Davis S., Ryan G., et al. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother. Oncol. 52 (1999) 129-136
3. Belani C.P., Choy H., Bonomi P., Scott C., Travis P., Haluschak J., et al. Combined chemotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J. Clin. Oncol. 23 (2005) 5883-5891
4. Belani C.P., Wang W., Johnson D.H., Wagner H., Schiller H., Veeder M., et al. Induction chemotherapy followed by standard thoracic radiotherapy (Std.TRT) vs hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage III A & B non-small cell lung cancer (NSCLC): Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597) (abstract). Proc. Am. Soc. Clin. Oncol. (2003) 622
5. Belderbos J.S., De Jaeger K., Heemsbergen W.D., Seppenwoolde Y., Baas P., Boersma L.J., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother. Oncol. 66 (2003) 119-126
6. Blackstock A.W., Lesser G.J., Fletcher-Steede J., Case L.D., Tucker R.W., Russo S.M., et al. Phase I study of twice-weekly gemcitabine and concurrent thoracic radiotherapy for patients with locally advanced non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 1281-1289
7. Blanke C., Ansari R., Mantravadi R., Gonin R., Tokars R., Fisher W., et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. J. Clin. Oncol. 13 (1995) 1425-1429
8. Bradley J.D., Paulus R., Graham M.V., Ettinger D.S., Johnstone D.W., Pilepich M.V., et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. J. Clin. Oncol. 23 (2005) 3480-3487
9. Brodin O., Nou E., Mercke C., Linden C.J., Lundstrom R., Arwidi A., et al. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group. Eur. J. Cancer 32A (1996) 1893-1900
10. Cakir S., and Egehan I. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer. Lung Cancer 43 (2004) 309-316
11. Chen G.Y., Jiang G.L., Qian H., Wang L.J., Yang H.J., Fu X.L., et al. Escalated hyperfractionated accelereted radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial. Radiother. Oncol. 71 (2004) 157-162
12. Choy H., Devore III R.F., Hande K.R., Porter L.L., Rosenblatt P., Yunus F., et al. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study). Int. J. Radiat. Oncol. Biol. Phys. 47 (2000) 931-937
13. Choy H., Swann S., Walter C., Whipple G., Demas W., and Ettinger D. A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: an RTOG study (abstract). Proc. Am. Soc. Clin. Oncol. 24 (2005) 646S
14. Cullen M.H., Billingham L.J., Woodroffe C.M., Chetiyawardana A.D., Gower N.H., Joshi R., et al. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J. Clin. Oncol. 17 (1999) 3188-3194
15. Curran W.J., Scott C., and Langer R. Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small-cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410 (abstract). Proc. Am. Soc. Clin. Oncol. 1891 (2000) 484a
16. Dillman R.O., Herndon J., Seagren S.L., Eaton Jr. W.L., and Green M.R. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J. Natl. Cancer Inst. 88 (1996) 1210-1215
17. Dillman R.O., Seagren S.L., Propert K.J., Guerra J., Eaton W.L., Perry M.C., et al. A randomized trial of induction chemotherapy plus high-dose versus radiation alone in stage III non-small cell lung cancer. N. Engl. J. Med. 323 (1990) 940-945
18. Fossella F.V., Zinner R.G., Komaki R., Lu R., Lee J.S., Glisson B.S., et al. Gemcitabine with concurrent chest radiation followed by consolidation chemotherapy with gemcitabine plus cisplatin: a phase I trial for patients with stage III non-small cell lung cancer. Proc. Am. Soc. Clin. Oncol. 20 (2001) 1243 (abstract)
19. Fournel P., Robinet G., Thomas P., et al. Groupe Lyon-Saint-Etienne d'oncologie thoracique-groupe français de pneumocancérologie. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer : groupe Lyon-Saint-Etienne d'oncologie thoracique-groupe français de pneumocancérologie NPC 95-01 Study. J. Clin. Oncol. 23 (2005) 5910-5917
20. Fu X.L., Jiang G.L., Wang L.J., Qian H., Fu S., Yie M., et al. Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial. Int. J. Radiat. Oncol. Biol. Phys. 39 (1997) 545-552
21. Furuse K., Fukuoka M., Kawahara M., Nishikawa H., Takada Y., Kudoh S., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J. Clin. Oncol. 17 (1999) 2692-2699
22. Gandara D.R., Chansky K., Albain K.S., Leigh B.R., Gaspar L.E., Lara Jr. P.N., et al., Southwest Oncology Group. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504. J. Clin. Oncol. 21 (2003) 2004-2010
23. Gervais R., Ducolone A., Le chevalier T., Legroumellec A., Lemarie E., Quoix E., et al. Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatin (P)]: final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT (abstract). Proc. Am. Soc. Clin. Oncol. 24 (2005) 646S
24. Girard N., and Mornex F. Chimiothérapie concomitante des cancers bronchiques. Bull. Cancer 92 (2006) 1048-1064
25. Hayman J.A., Martel M.K., Ten Haken R.K., Normolle D.P., Todd III R.F., Littles J.F., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J. Clin. Oncol. 19 (2001) 127-136
26. Huber R.M., Flentje M., Gosse H., Poellinger B., Schmidt M., Willner J., et al. Induction chemotherapy and following simultaneous radiochemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (Stage IIIA/IIIB) : Update of CT/RT 99/97 (abstract). Proc. Am. Soc. Clin. Oncol. (2004) 635S
27. Ishikura S., Ohe Y., Nihei K., Kubota K., Kakinuma R., Ohmatsu H., et al. A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC). Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 1117-1122
28. Jeremic B., Milicic B., Acimovic L., and Milisavljevic S. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study. J. Clin. Oncol. 23 (2005) 6873-6880
29. Jeremic B., Milicic B., Dagovic A., Aleksandrovic J., and Milisavljevic S. Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy: retrospective analysis of 301 patients. Am. J. Clin. Oncol. 27 (2004) 350-360
30. Jeremic B., Shibamoto Y., Acimovic L., and Djuric L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J. Clin. Oncol. 13 (1995) 452-458
31. Jeremic B., Shibamoto Y., Acimovic L., and Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J. Clin. Oncol. 14 (1996) 1065-1070
32. Johnson D.H., Einhorn L.H., Bartolucci A., Birch R., Omura G., Perez C.A., et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann. Intern. Med. 113 (1990) 33-38
33. Komaki R., Seiferheld W., Ettinger D., Lee J.S., Movsas B., and Sause W. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 548-557
34. Kubota K., Furuse K., Kawahara M., Kodama N., Yamamoto M., Ogawara M., et al. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer. J. Clin. Oncol. 12 (1994) 1547-1552
35. Le Chevalier T., Arriagada R., Quoix E., Ruffie P., Martin M., Tarayre M., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in non resectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J. Natl. Cancer Inst. 83 (1991) 417-423
36. Lee J.S., Komaki R., Fossella F.V., Glisson B.S., Hong W.K., and Cox J.D. A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report. Int. J. Radiat. Oncol. Biol. Phys. 42 (1998) 479-486
37. Lee S.W., Choi E.K., Lee J.S., Lee S.D., Suh C., Kim S.W., et al. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine and cisplatin chemotherapy for stage III locally advanced, unresectable non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 996-1004
38. Marks L.B., Garst J., Socinski M.A., Sibley G., Blackstock A.W., Zhou J.E., et al. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina conformal therapy consortium. J. Clin. Oncol. 22 (2004) 4329-4340
39. Mattson K., Holsti L.R., Holsti P., Jakobsson M., Kajanti M., Liippo K., et al. Inoperable non-small cell lung cancer: radiation with or without chemotherapy. Eur. J. Cancer Clin. Oncol. 24 (1988) 477-482
40. Miller G.M., Kim D.W., Andres M.L., Green L.M., and Gridley D.S. A randomized trial of chemotherapy and radiotherapy for stage III non small cell lung cancer. Cancer Ther. 1 (1998) 229-236
41. Mornex F., Bellière A., Chapet O., Fleury B., Khodri M., and Kubas M. Lung and lent toxicity analysis of a combined 3D high dose chemoradiation protocol. Recommendation for further studies. Lung Cancer 49 (2005) S77
42. Mornex F., and Girard N. Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art. Ann. Oncol. (2006) (sous presse)
43. Morton R.F., Jett J.R., McGinnis W.L., Earle J.D., Therneau T.M., Krook J.E., et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann. Intern. Med. 115 (1991) 681-686
44. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
45. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311 (1995) 899-909
46. Oral E.N., Bavbek S., Kizir A., Tenececi N., Yoney A., Kaytan E., et al. Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer. Lung Cancer 25 (1999) 191-198
47. Perez C.A., Pajak T.F., Rubin P., Simpson J.R., Mohiuddin M., Brady L.W., et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59 (1987) 1874-1881
48. Pisch J., Berson A.M., Malamud S., Beattie E.J., Harvey J., and Vikram B. Chemoradiation in advanced nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 33 (1995) 183-188
49. Pöttgen C., Eberhardt W., Bildat S., Stüben G., Stamatis G., Hillijan L., et al. Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb):a pilot phase I/II trial. Ann. Oncol. 13 (2002) 403-411
50. Reinfuss M., Glinski B., Kowalska T., Kulpa J., Zawila K., Reinfuss K., et al. Radiothérapie du cancer bronchique non à petites cellules de stade III, inopérable, asymptomatique. Résultats définitifs d'un essai prospectif randomisé (240 patients). Cancer Radiother. 3 (1999) 475-479
51. Rosenman J.G., Halle J.S., Socinski M.A., Deschesne K., Moore D.T., Johnson H., et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. Int. J. Radiat. Oncol. Biol. Phys. 54 (2002) 348-356
52. Roswit B., Patno M.E., Rapp R., Veinbergs A., Feder B., Stuhlbarg J., et al. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 90 (1968) 688-697
53. Saunders M., Dische S., Barrett A., Harvey A., Griffiths G., and Parmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer : mature data from the randomised multicentre trial. Radioth. Oncol 52 (1999) 137-148
54. Sause W.T., Scott C., Taylor S., Johnson D., Livingston R., Komaki R., et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J. Natl. Cancer Inst. 87 (1995) 198-205
55. Scalliet P., Goor C., Galdermans D., van Meerbeek J., Groen H.J., van de Leest A.H.D., et al. Gemzar® (gemcitabine) with thoracic radiotherapy - a phase II pilot study in chemonaive patients with advanced non-small cell lung cancer (abstract). Proc. Am. Soc. Clin. Oncol. 17 (1998) 499a
56. Schaake-Koning C., van den Bogaert W., Dalesio O., Festen J., Hoogenhout J., van Houtte P., et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N. Engl. J. Med. 326 (1992) 524-530
57. Schild S.E., Stella P.J., Geyer S.M., Bonner J.A., Marks R.S., McGinnis W.L., et al. Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 54 (2002) 370-378
58. Sim S.S., Rosenzweig K.E., Schindelheim R., Ng K.K., and Leibel S.A. Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 660-665
59. Socinski M.A., Morris D.E., Halle J.S., Moore D.T., Hensing T.A., Limentani S.A., et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J. Clin. Oncol. 22 (2004) 4341-4350
60. Soresi E., Clerici M., Grilli R., Borghini U., Zucali R., and Leoni M. A randomized clinical trial comparing radiation therapy plus cisdiaminedichloroplatinium (II) in the treatment of advanced non-small cell lung cancer. Semin. Oncol. 15 (1988) 20
61. Trodella L., Cortesi E., D'Angelillo R.M., Ramella S., Nelli F., Cesario A., et al. Concurrent radio chemotherapy with weekly gemcitabine in IIIaN2 non-small cell lung cancer: analysis of an ongoing phase II trial (abstract). Proc. Am. Soc. Clin. Oncol. 22 (2003) 675
62. Trovo M.G., Minatel E., Franchin G., Boccieri M.G., Nascimben O., Bolzicco G., et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 24 (1992) 11-15
63. Trovo M.G., Minatel E., Veronesi A., Roncadin M., De Paoli A., Franchin G., et al. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma. A randomized study. Cancer 65 (1990) 400-404
64. van Meerbeeck J.P., Kramer G., van Schil P.E., Legrand C., Smit E.F., Schramel F.M., et al. EORTC-Lung Cancer Group. A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941) (abstract). Proc. Am. Soc. Clin. Oncol. 24 (2005) 624S
65. van Putten J.W., Price A., van der Leest A.H., Gregor A., Little F.A., and Groen H.J. A phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer. Clin. Cancer Res. 9 (2003) 2472-2477
66. Vokes E.E., Herndon II J.E., Crawford J., Leopold K.A., Perry M.C., Miller A.A., et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIb non-small-cell lung cancer: cancer and leukemia group B study 9431. J. Clin. Oncol. 20 (2002) 4191-4198
67. Vokes E.E., Herndon J.E., Kelley M.J., Watson D., Cicchetti M.G., and Green M.R. Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): Initial analysis of a randomized phase III trial (abstract). Proc. Am. Soc. Clin. Oncol. (2004) 618S
68. White J.E., Chen T., Reed R., Mira J., Stuckey W.J., Weatherall T., et al. Limited Squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy. Cancer Treat. Rep. 66 (1982) 1113-1120
69. Wu K.L., Jiang G.L., Lioa Y., Qian H., Wang L.J., Fu X.L., et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 1336-1344
70. Zatloukal P., Petruzelka L., Zemanova M., Havel L., Janku F., Judas L., et al. Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized study. Lung Cancer 46 (2004) 87-98